One of the main goal of our research is personalised medicine. We are involved in different projects regarding human health, spanning from population genomics to neurodegenerative disorders.
The ultimate goal of the project is the development of new products and services such as functional foods, personalized diet, supplements, nutraceuticals, kit for early diagnosis to enable the recognition of genetic variants and risk of new biomarkers for cardiovascular diseases.
The aim of the project is to build a Regional Biobank accompanied by clinical, historical, environmental and biological data, for the identification of the main causes of multifactorial diseases and dissect gene-environment relationships.
The main objective of this project is to develop a research network including private and public institutions focused on the exchange of expertise in imaging, genomics and bioinformatics to be utilized in monitoring therapies and disease progression in severe allergic asthma (AA).
Parkinson Disease (PD) is the second most common progressive neurodegenerative disorder, affecting 1-2% of all individuals above the age of 65. We propose to apply a highly interdisciplinary approach to construct complex networks consisting of protein coding genes, non-protein-coding genes and cis-regulatory elements within dopaminergic neurons in the brain.
Study of the molecular mechanisms implicated in the pathogenesis of cerebellar vermis hypoplasia exploiting the Opitz Syndrome mouse model.